Phenomenex introduces the Biozen Native RP-1 and RP-5 columns—innovative tools designed to improve Antibody-Drug Conjugate (ADC) analysis in pharmaceutical and biotherapeutic research. Tailored for native reversed-phase chromatography with online mass spectrometry (MS) detection, these columns simplify workflows and enhance data reliability.
By maintaining the native state of ADCs during separation, the Biozen Native RP technology provides more accurate molecular insights and supports faster decision-making in lead candidate selection and optimization. This innovation is particularly valuable for lab managers aiming to maximize throughput and minimize downtime without compromising data quality.
Empowering lab managers with smarter chromatographic tools
The proprietary surface chemistry and particle design of the RP-1 and RP-5 columns ensure consistent, high-resolution separation of Drug to Antibody Ratio (DAR) species, including difficult-to-resolve isomers. These performance gains translate into shorter run times and reduced sample handling—delivering cost-effective and scalable solutions for busy laboratories.
Key Benefits for Lab Managers
- Higher throughput through reduced run times
- Streamlined sample preparation and minimal handling
- Reliable resolution of all DAR species, including isomers
- Compatibility with online MS for real-time insights
- Improved reproducibility and data consistency
- Ideal for ADC characterization in therapeutic development
Phenomenex continues to lead in laboratory innovation, equipping research teams with the tools necessary to meet growing demands in biologic drug development.
